Your browser doesn't support javascript.
loading
Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2.
Adamska, Julia Z; Verma, Rohit; Gupta, Shakti; Hagan, Thomas; Wimmers, Florian; Floyd, Katharine; Li, Qin; Valore, Erika V; Wang, Yanli; Trisal, Meera; Vilches-Moure, José G; Subramaniam, Shankar; Walkley, Carl R; Suthar, Mehul S; Li, Jin Billy; Pulendran, Bali.
  • Adamska JZ; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA; Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Verma R; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA.
  • Gupta S; Department of Bioengineering, University of California, San Diego, San Diego, CA 92093, USA.
  • Hagan T; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Wimmers F; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA.
  • Floyd K; Department of Pediatrics, Department of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Center, Emory School of Medicine, Atlanta, GA 30329, USA.
  • Li Q; Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Valore EV; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA.
  • Wang Y; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA.
  • Trisal M; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA.
  • Vilches-Moure JG; Department of Comparative Medicine, Stanford University, Stanford, CA 94305, USA.
  • Subramaniam S; Department of Bioengineering, University of California, San Diego, San Diego, CA 92093, USA.
  • Walkley CR; St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia.
  • Suthar MS; Department of Pediatrics, Department of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Center, Emory School of Medicine, Atlanta, GA 30329, USA.
  • Li JB; Department of Bioengineering, University of California, San Diego, San Diego, CA 92093, USA.
  • Pulendran B; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA 94304, USA; Department of Pathology, Stanford University, Stanford, CA 94305, USA; Department of Microbiology & Immunology, Stanford University, Stanford, CA 94305, US
Cell Rep ; 42(1): 112038, 2023 01 31.
Article en En | MEDLINE | ID: mdl-36732946
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article